Navigation Links
Kenneth A. Sylvia Named as New Publisher of Current Psychiatry
Date:1/8/2008

MONTVALE, N.J., Jan. 8 /PRNewswire/ -- Jennifer J. Day, Senior Vice President and Group Publisher at Dowden Health Media (DHM), announces the addition of Kenneth A. Sylvia as publisher of Current Psychiatry.

"Ken is a seasoned veteran in the healthcare industry who brings to DHM 30 years of experience and recognition across the media, account, and product management client bases we serve," Day said. DHM is a subsidiary of Lebhar- Friedman, Inc.

Ken spent the first 20 years of his publishing career at Cliggott Publishing in Greenwich, CT. Notably, he launched the Journal of Critical Illness, an internal medicine specialty publication, and managed the successful turnaround of Consultant in the early 1990's. Ken then established Alliance Medical Communications-leading to the introduction of Women's Health in Primary Care-where, following the company's sale to Jobson, he spent the next 4 years in management positions. Most recently, Ken was part of the team at Hearst Business Media's Diversion.

Ken's publishing industry excellence earned him the industry's prestigious Sales Representative of the Year Award now known as the Nexus Award. He also has served as president of AMP (now the Association of Medical Media) in 1999 and on the AMP board from 1994 to 2002.

Current Psychiatry, founded in 2002, has quickly established itself as one of the premier, best-read publications serving the psychiatry specialty market. Current Psychiatry is a peer-reviewed journal providing readers with practical advice written by leading authorities, emphasizing solutions to common clinical problems. The monthly publication-with a circulation of 39,000 psychiatrists and psychiatric nurse practitioners-is published through an educational partnership with the University of Cincinnati College of Medicine's Department of Psychiatry.


'/>"/>
SOURCE Dowden Health Media
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Siemens Congratulates Kenneth R. Bertka, M.D., Recipient of 2007 AMDIS Award
2. Ravenell named recipient of grant from Robert Wood Johnson Foundation
3. Brown named Center of Excellence in Geriatric Medicine and Training
4. International Aid Named as a MinistryWatch.com Shining Light Christian Ministry
5. Rhodes Named Head of Health Plan Administration Company TCC
6. PartsSource Named 2007 Weatherhead 100 Award Winner
7. Novadaqs SPY Imaging System named Product of the Year by Frost and Sullivan
8. Florida Boy Named CNN Heroes Viewers Choice Winner
9. OPKOs Bevasiranib Named One of Most Promising Drugs Recently Entering Phase III Trials
10. Rh-Apo2L Named as One of Chinas High-Tech Transforming Products by Chinese Government
11. Yale Neurosurgeon Named American Epilepsy Society President
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... Shanghai, China (PRWEB) December 22, 2014 ... for MabThera (rituximab) for the treatment of non-Hodgkin’s lymphoma ... Health , a leading global healthcare consulting firm. MabThera ... B-cell lymphoma (DLBCL), the most common form of NHL. ... Market Access and Barriers,” the incidence of NHL in ...
(Date:12/22/2014)... Give a loved one the greatest ... health and vitality. , For a limited time, HealthiPlus ... formulas in special Holiday Wellness gift packages at drastically ... Each bottle contains cutting-edge, proven nutritional support for joints, ... well as we age. , Joint Health ...
(Date:12/22/2014)... Texas (PRWEB) December 22, 2014 7,178 ... and bustle of Black Friday shopping and opted instead ... and marketing education company, for their 5th annual “Black ... charged just $7 to attend the 5 hour ... that they promptly donated to support two Central Texas ...
(Date:12/22/2014)... December 22, 2014 NAPW ... Professional Woman of the Year. She is recognized with ... largest, most recognized networking organization of professional women in ... National Association of Professional Women is a vibrant networking ... Chapters. , Ms. Kreider is passionate and committed to ...
(Date:12/21/2014)... 2014 In this report, the ... power source, product, and application. The market, by ... pneumatic instruments. By product, the market covers the ... The handpieces market is further subdivided into drills, ... laparoscopic instruments, shavers, wire/pin drivers, and others. Moreover, ...
Breaking Medicine News(10 mins):Health News:Physicians in China See Most Significant Demand for MabThera Biosimilar 2Health News:Physicians in China See Most Significant Demand for MabThera Biosimilar 3Health News:You Still Have Time to Give the Gift of Health and Vitality to a Mature Loved One 2Health News:Austin Company Digital Marketer Raises 100K to Fight Childhood Cancer 2Health News:Austin Company Digital Marketer Raises 100K to Fight Childhood Cancer 3Health News:National Association of Professional Women Announces Cheryl A. Kreider, President / CEO of Kreider Health Solutions, LLC, a 2014 Professional Woman of the Year 2Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 2Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 3Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 4
... Australian-based,natural health care products company that markets a range ... nature identical ingredients,announced today that its Quit Nits head ... United States through a distribution agreement with,CVS Pharmacies., ... agreement was the,result of two years of hard work ...
... identified a gene that is the key switch that ... , Much like students in a kindergarten class lining ... is identified as Smarcd3, must align correctly with two ... known as myogenesis, said principal investigator Monte Westerfield, a ...
... is a company with a renowned track record ... high throughput technologies. Genomatix algorithms include optimized fast ... complete genome annotation in terms of transcriptome and ... databases in this specific content by a factor ...
... of us probably don,t think much,about being regular, ... Johanson,practicing gastroenterologist at the Beloit Clinic in Beloit, ... health is that we,re,not getting enough fiber., ... http://media.medialink.com/WebNR.aspx?story=34435 Registered journalists can access video, ...
... the top killers in the country, but youd never know it ... of the Society for Critical Care Medicine (SCCM). , Research ... blood pressure, yet many of them dont even know it. ... the medications they need to control it," says Dr. Christopher Granger, ...
... improves access by ... care facilities and consumers, BUFFALO, N.Y., Jan. ... health care provider network to provide,routine wellness and ... the company announced today., HealthTransaction Network connects ...
Cached Medicine News:Health News:Wild Child's 'Quit Nits' Offers a Safe, Natural Alternative to Current Toxic Head Lice Products 2Health News:Wild Child's 'Quit Nits' Offers a Safe, Natural Alternative to Current Toxic Head Lice Products 3Health News:Oregon researchers find trigger gene for muscle development 2Health News:Severe hypertension: 'Silent killer' still on the loose 2Health News:Buffalo Company Launches First-ever National Electronic Transaction Network to Improve Health Care Access for Uninsured and Underinsured 2Health News:Buffalo Company Launches First-ever National Electronic Transaction Network to Improve Health Care Access for Uninsured and Underinsured 3
(Date:12/22/2014)... Cyberonics, Inc. (NASDAQ: CYBX ), a ... of epilepsy, today announced it will participate in the 33 ... 14, 2015, in San Francisco . ... Officer, will speak at 11:00 AM Pacific Time.  A live ... on the Investor Relations link on the Cyberonics home page ...
(Date:12/22/2014)... , Dec, 22, 2014  Eiger BioPharmaceuticals Incorporated ... study of lonafarnib in patients with chronic hepatitis ... at the National Institutes of Health (NIH) Clinical ...  The double-blinded, randomized, placebo-controlled, dose ascending study evaluated ... and 200 mg twice daily for 28 days.  ...
(Date:12/19/2014)... WAYNE, N.J. , Dec. 19, 2014  In the Friday, ... , a 16-page supplement dedicated to Healthcare Information Technology (HIT) features ... innovation in Healthcare IT in partnership with several leading healthcare organizations. ... be distributed across several major metropolitan markets, such as ... Washington DC / Baltimore , Minneapolis ...
Breaking Medicine Technology:Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 2Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 3USA Today Supplement Featuring Konica Minolta Focuses on Impact of Healthcare IT 2
... published online in the journal Current Medical Research and ... type 2 diabetes treated with the fixed-dose combination ACTO plus ... reached the study goal of hemoglobin A1c (HbA1c) of less ... alone. Safety and tolerability of ACTO plus met therapy ...
... CHANGCHUN, China and LOS ANGELES, Oct. 14 /PRNewswire-Asia/ ... Yongxin,Pharmaceuticals" or "the Company"), a leading manufacturer, distributor and,retailer ... results for the second quarter of 2009 which ended ... the second quarter of 2009 were essentially flat at,approximately ...
Cached Medicine Technology:New Data Showed Type 2 Diabetes Patients Experienced Greater Blood Sugar Reductions when Treated with ACTOplus met(R) (pioglitazone HCl and metformin HCl) as Initial Therapy Compared to Either Component Alone 2New Data Showed Type 2 Diabetes Patients Experienced Greater Blood Sugar Reductions when Treated with ACTOplus met(R) (pioglitazone HCl and metformin HCl) as Initial Therapy Compared to Either Component Alone 3New Data Showed Type 2 Diabetes Patients Experienced Greater Blood Sugar Reductions when Treated with ACTOplus met(R) (pioglitazone HCl and metformin HCl) as Initial Therapy Compared to Either Component Alone 4New Data Showed Type 2 Diabetes Patients Experienced Greater Blood Sugar Reductions when Treated with ACTOplus met(R) (pioglitazone HCl and metformin HCl) as Initial Therapy Compared to Either Component Alone 5New Data Showed Type 2 Diabetes Patients Experienced Greater Blood Sugar Reductions when Treated with ACTOplus met(R) (pioglitazone HCl and metformin HCl) as Initial Therapy Compared to Either Component Alone 6China Yongxin Pharmaceuticals Inc. Announces Second Quarter 2009 Financial Results 2China Yongxin Pharmaceuticals Inc. Announces Second Quarter 2009 Financial Results 3China Yongxin Pharmaceuticals Inc. Announces Second Quarter 2009 Financial Results 4China Yongxin Pharmaceuticals Inc. Announces Second Quarter 2009 Financial Results 5China Yongxin Pharmaceuticals Inc. Announces Second Quarter 2009 Financial Results 6China Yongxin Pharmaceuticals Inc. Announces Second Quarter 2009 Financial Results 7China Yongxin Pharmaceuticals Inc. Announces Second Quarter 2009 Financial Results 8China Yongxin Pharmaceuticals Inc. Announces Second Quarter 2009 Financial Results 9China Yongxin Pharmaceuticals Inc. Announces Second Quarter 2009 Financial Results 10China Yongxin Pharmaceuticals Inc. Announces Second Quarter 2009 Financial Results 11
... The AFX Lens is ... for use in an air-filled ... use as a primary air-fluid ... profile and sutureless design make ...
... 45° Prism is designed ... and are recommended for ... BRVO etc.) and Rhegmatogenus ... be used for panretinal ...
... Chalam Flat is designed for ... and induction of posterior vitreous ... for macula whole surgery, epiretinal ... tractional epiretinal membranes. Direct image ...
... magnification and increased stereopsis, the Central Retinal ... to the equatorial regions. The Central Retinal ... in membrane peeling in proliferative vitreoretinopathy extending ... The ACS Vitrectomy Lenses from Volk can ...
Medicine Products: